Letitia C. Fulcher

784 total citations
14 papers, 573 citations indexed

About

Letitia C. Fulcher is a scholar working on Molecular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Letitia C. Fulcher has authored 14 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Medicine, 3 papers in Infectious Diseases and 3 papers in Molecular Biology. Recurrent topics in Letitia C. Fulcher's work include Antibiotic Resistance in Bacteria (4 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Pneumonia and Respiratory Infections (3 papers). Letitia C. Fulcher is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Bacterial Identification and Susceptibility Testing (3 papers) and Pneumonia and Respiratory Infections (3 papers). Letitia C. Fulcher collaborates with scholars based in United States. Letitia C. Fulcher's co-authors include Manuel Hidalgo, William E. Friedrichs, Linda A. deGraffenried, Viktor Grünwald, James H. Jorgensen, M. Leticia McElmeel, Josep Maria Peralba, Ratna B. Ray, Geoffrey R. Weiss and Joshua S. Hawley and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Annals of Oncology.

In The Last Decade

Letitia C. Fulcher

14 papers receiving 560 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Letitia C. Fulcher United States 10 312 128 111 64 62 14 573
Yonglie Zhou China 12 198 0.6× 148 1.2× 92 0.8× 40 0.6× 73 1.2× 32 531
Linying Zhou China 15 413 1.3× 74 0.6× 73 0.7× 120 1.9× 64 1.0× 38 796
Hideaki Miwa Japan 17 218 0.7× 78 0.6× 266 2.4× 89 1.4× 33 0.5× 65 840
Chuxiao Shao China 13 218 0.7× 89 0.7× 93 0.8× 89 1.4× 120 1.9× 65 641
Jennifer L. Hoover United States 14 308 1.0× 289 2.3× 118 1.1× 160 2.5× 32 0.5× 23 883
Helena Ramos Portugal 17 385 1.2× 295 2.3× 174 1.6× 115 1.8× 131 2.1× 38 863
Zhuo Cao China 12 175 0.6× 86 0.7× 59 0.5× 76 1.2× 56 0.9× 27 391
Luning Zhuang United States 17 186 0.6× 239 1.9× 107 1.0× 144 2.3× 31 0.5× 24 643
Hongzhi Sun China 11 224 0.7× 38 0.3× 69 0.6× 57 0.9× 49 0.8× 12 366

Countries citing papers authored by Letitia C. Fulcher

Since Specialization
Citations

This map shows the geographic impact of Letitia C. Fulcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Letitia C. Fulcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Letitia C. Fulcher more than expected).

Fields of papers citing papers by Letitia C. Fulcher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Letitia C. Fulcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Letitia C. Fulcher. The network helps show where Letitia C. Fulcher may publish in the future.

Co-authorship network of co-authors of Letitia C. Fulcher

This figure shows the co-authorship network connecting the top 25 collaborators of Letitia C. Fulcher. A scholar is included among the top collaborators of Letitia C. Fulcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Letitia C. Fulcher. Letitia C. Fulcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Johnson, David W., et al.. (2015). Potency and Sterility of Fortified Tobramycin, Fortified Vancomycin, and Moxifloxacin at 4, 24, and 35°C for 14 Days. Cornea. 35(1). 122–126. 9 indexed citations
2.
Dallas, Steven D., Lesley McGee, Brandi Limbago, et al.. (2013). Development of Doxycycline MIC and Disk Diffusion Interpretive Breakpoints and Revision of Tetracycline Breakpoints for Streptococcus pneumoniae. Journal of Clinical Microbiology. 51(6). 1798–1802. 15 indexed citations
3.
Jorgensen, James H., M. Leticia McElmeel, Letitia C. Fulcher, et al.. (2011). Collaborative Evaluation of an Erythromycin-Clindamycin Combination Well for Detection of Inducible Clindamycin Resistance in Beta-Hemolytic Streptococci by Use of the CLSI Broth Microdilution Method. Journal of Clinical Microbiology. 49(8). 2884–2886. 5 indexed citations
4.
Fulcher, Letitia C., et al.. (2011). The outpatient institutional antibiogram does not accurately reflect the susceptibility of prepartum group B streptococcal isolates to erythromycin and clindamycin. Diagnostic Microbiology and Infectious Disease. 71(4). 457–459. 2 indexed citations
5.
Jorgensen, James H., M. Leticia McElmeel, Letitia C. Fulcher, Lesley McGee, & Anita Glennen. (2011). Evaluation of Disk Approximation and Single-Well Broth Tests for Detection of Inducible Clindamycin Resistance in Streptococcus pneumoniae. Journal of Clinical Microbiology. 49(9). 3332–3333. 8 indexed citations
6.
Campbell, Jennifer D., James S. Lewis, M. Leticia McElmeel, Letitia C. Fulcher, & James H. Jorgensen. (2011). Detection of Favorable Oral Cephalosporin-Clavulanate Interactions by In Vitro Disk Approximation Susceptibility Testing of Extended-Spectrum-Beta-Lactamase-Producing Members of the Enterobacteriaceae. Journal of Clinical Microbiology. 50(3). 1023–1026. 9 indexed citations
7.
Bowling, Jason E., et al.. (2010). Detection of Inducible Clindamycin Resistance in Beta-Hemolytic Streptococci by Using the CLSI Broth Microdilution Test and Erythromycin-Clindamycin Combinations. Journal of Clinical Microbiology. 48(6). 2275–2277. 8 indexed citations
8.
Jorgensen, James H., M. Leticia McElmeel, Letitia C. Fulcher, & Barbara Zimmer. (2009). Detection of CTX-M-Type Extended-Spectrum Beta-Lactamase (ESBLs) by Testing with MicroScan Overnight and ESBL Confirmation Panels. Journal of Clinical Microbiology. 48(1). 120–123. 24 indexed citations
9.
Jorgensen, James H., Sharon A. Crawford, Letitia C. Fulcher, et al.. (2006). Multilaboratory Evaluation of Disk Diffusion Antimicrobial Susceptibility Testing of Neisseria meningitidis Isolates. Journal of Clinical Microbiology. 44(5). 1744–1754. 11 indexed citations
10.
Hawley, Joshua S., Clinton K. Murray, Matthew E. Griffith, et al.. (2006). Susceptibility of Acinetobacter Strains Isolated from Deployed U.S. Military Personnel. Antimicrobial Agents and Chemotherapy. 51(1). 376–378. 104 indexed citations
11.
deGraffenried, Linda A., Letitia C. Fulcher, William E. Friedrichs, et al.. (2004). Reduced PTEN expression in breast cancer cells confers susceptibility to inhibitors of the PI3 kinase/Akt pathway. Annals of Oncology. 15(10). 1510–1516. 145 indexed citations
12.
deGraffenried, Linda A., William E. Friedrichs, Letitia C. Fulcher, et al.. (2003). Eicosapentaenoic acid restores tamoxifen sensitivity in breast cancer cells with high Akt activity. Annals of Oncology. 14(7). 1051–1056. 58 indexed citations
13.
Peralba, Josep Maria, Linda A. deGraffenried, William E. Friedrichs, et al.. (2003). Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients.. PubMed. 9(8). 2887–92. 148 indexed citations
14.
Salman, Mohammad, et al.. (1991). 17α -Substituted analogs of estradiol for the development of fluorescent estrogen receptor ligands. Steroids. 56(7). 375–387. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026